Clinical Trial Update: Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of Defibrotide [Phase 2, Phase 3]

View source ↗

Summary

A completed pediatric Phase 2/3 trial evaluated prophylactic defibrotide to assess incidence and outcomes of hepatic veno-occlusive disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Veno-occlusive Disease

Drugs mentioned

• Defitelio (defibrotide)

Snippet

Sponsor: European Society for Blood and Marrow Transplantation | Conditions: Hepatic Veno-Occlusive Disease | Phase 2, Phase 3 | Status: COMPLETED